Dr. Levy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6901 Snider Plz
Ste 200
Dallas, TX 75205Phone+1 214-369-7733Fax+1 214-360-9604
Summary
- Dr. Richard Levy is an orthopaedic surgeon based in Dallas, TX, specializing in sports medicine and shoulder and elbow surgery. He earned his medical degree from Tulane University School of Medicine in 1990 and completed his residency in orthopaedic surgery there from 1991 to 1995, following a transitional internship. Dr. Levy has contributed to several notable publications, including research on inflammatory cell markers and myelofibrosis, with his work being cited multiple times in various reputable journals. He has been recognized as a Super Doctor by SuperDoctors.com.
Education & Training
Tulane UniversityResidency, Orthopaedic Surgery, 1991 - 1995- Tulane UniversityInternship, Transitional Year, 1990 - 1991
- Tulane University School of MedicineClass of 1990
Certifications & Licensure
TX State Medical License 1996 - 2025
FL State Medical License 2011 - 2022
GA State Medical License 1992 - 1997
LA State Medical License 1990 - 1997- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 43 citationsDownmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitor.Naresh Punwani, Timothy Burn, Peggy Scherle, Robert Flores, Jack G. Shi
The British Journal of Dermatology. 2015-10-01 - 41 citationsEfficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, Richard S Levy, Vikas Gupta
Haematologica. 2015-04-01 - 34 citationsComparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A. Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, Haifa Kathrin Al-Ali, Jason Gotlib
Haematologica. 2014-02-01
Press Mentions
Masks No Longer Required for Illinois’ Vaccinated Students, Teachers as State Adopts New CDC GuidanceJuly 9th, 2021
MADRIGAL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (Form 8-K)August 11th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
